Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59(R). Frey SE, Brady R, Jackson L, Goepfert P, et al. Vaccine 2025;47:126702.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frey SE, Brady R, Jackson L, Goepfert P, et al. Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59(R). Vaccine 2025;47:126702.
PMID: 39798434